Table 3.
Characteristics | Survivors (n = 44) | Non-survivors (n = 27) | Multivariate analysis |
|
---|---|---|---|---|
OR (95% CI) | p | |||
Sex, male | 22 (50%) | 20 (74.1%) | 3.47 (0.79–15.21) | 0.098 |
Age, years | 65.34 ± 15.70 | 69.62 ± 12.77 | 1.05 (0.99–1.11) | 0.095 |
Lung disease | 9 (20.5%) | 11 (40.7%) | 1.48 (0.33–6.52) | 0.604 |
DM | 20 (45.5%) | 7 (25.9%) | 0.25 (0.05–1.19) | 0.082 |
Cerebrovascular disease | 24 (54.5%) | 6 (22.2%) | 0.37 (0.08–1.76) | 0.215 |
Pitt bacteremia score | 3.25 ± 2.22 | 5.22 ± 2.22 | 1.63 (1.16–2.30) | 0.005 |
Type of infection-pneumonia | 13 (29.5%) | 18 (66.7%) | 5.27 (1.11–24.87) | 0.036 |
Combination therapy | 23 (52.3%) | 8 (29.6%) | 0.15 (0.03–0.65) | 0.011 |
Data are presented as mean±standard deviation, SD for continuous variables and as n (%) of patients for categorical variables. DM, diabetes mellitus.